Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular tranexamic acid with versus without drain clamping after cemented total knee replacement
IRCT20240217061034N2Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of tranexamic acid in postoperative hemorrhage (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoints: Bleeding volume and Hemoglobin level. Started Feb 2025; status: completed.
02
Drugs
tranexamic acid
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on IRCT20240217061034N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240217061034N2.